law.justia.com/cases/federal/appellate-courts/ca3/16-4075/16-4075-2018-06-27.html

Jun 27, 2018 ... Joni Westawski v. Merck & Co Inc, No. 16-4075 (3d Cir. 2018) case opinion from the US Court of Appeals for the Third Circuit.

law.justia.com/cases/federal/appellate-courts/cafc/16-2302/16-2302-2018-04-25.html

Apr 26, 2018 ... Merck's patents claim classes of compounds, identified by structural formulas, and the administration of therapeutically effective amounts of ...

law.justia.com/cases/massachusetts/supreme-court/2018/sjc-12347.html

A plaintiff who alleges that he was injured from his use of a generic drug because of a failure to warn of the drug's side effects cannot bring a common-law ...

www.justice.gov/atr/case/us-v-merck-co-inc-2010

Oct 4, 2016 ... Monday, March 29, 2010. Case Name: United States v. Merck & Co., Inc. Case Type: Civil Non-Merger. Case Violation: No Violation Assigned.

www.finnegan.com/en/tools/gilead-sciences-inc-v-merck-co-inc.html

Gilead Sciences, Inc. v. Merck & Co, Inc. Case. 5:13-cv-04057. Venue: U.S. District Court, N.D. California. Decision Type: Motion in Limine Ruling.

www.owler.com/company/merck

Gilead Sciences, Inc, a research─based biopharmaceutical company, has announced ... Pharmaceuticals field. Gilead has 59000 fewer employees vs. Merck.